Surprise as FDA Authorizes Sales of a Low-Temperature-Burning Tobacco Product in the United States

The United States Food and Drug Administration (FDA) announced that, as of 30 April 2019, it authorized the marketing of Philip Morris’s IQOS Tobacco Heating System products.
What is IQOS?
It is an electronic device that heats paper-wrapped sticks filled with tobacco. Marketed as heated but non-burning tobacco products, this device produces a mixture of vapor and smoke containing nicotine. IQOS consists of three parts: a holder, a tobacco-filled stick and a charger. This pen-like device contains a ceramic and gold plate that heats Philip Morris-branded tobacco sticks to 350 degrees. In regular e-cigarettes, tobacco burns at 600 degrees Celsius or higher. IQOS has the same nicotine content as conventional cigarettes!
IQOS is not actually a new device. Philip Morris International first began selling it in Japan and Italy in 2014. The group, which has sold its product in 40 different markets to date, says it has reached 7 million users. Sales of the product, previously prohibited in the United States, are intended to begin in Atlanta this summer following FDA authorization.
The FDA states that its authorization does not constitute approval of the device, but permits its sale . Its statement says that publications in peer-reviewed journals were reviewed and that it is a product preferable to conventional cigarettes. While recommending that nonsmokers not start, it also states that restrictions will be imposed on use by young people . Alongside the IQOS device, the company’s Marlboro HeatSticks, Marlboro Violet Heaters and Marlboro Menthol Heaters will also benefit from the authorization and may be offered for sale.
Although these devices are called “non-burning but heated” tobacco products, they are still defined as “cigarettes” under the United States Federal Food, Drug, and Cosmetic Act. They must therefore comply with existing cigarette restrictions under FDA regulations and other federal laws banning television and radio advertising. The FDA also restricts youth access to the products and exposure to advertising. It is stated that nicotine addiction warnings will appear on device packaging. The FDA will monitor youth use and marketing and determine its new policy accordingly.
In conclusion, Interpreting FDA policy, we believe that tobacco companies may open the door to new addictions through e-cigarettes and devices such as IQOS, particularly in the United States, where smoking rates have fallen. Because it contains the same amount of nicotine, the product may create the same addiction as regular cigarettes; its particular popularity among young people poses a major danger. What is needed is campaigns to stop smoking completely, rather than support for alternative tobacco products.
Related Topic:
Sources
fda.gov, 30 April 2019
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.